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Introduction: Since normal or high central venous oxygen saturation (ScvO2) values cannot discriminate if tissue
perfusion is adequate, integrating other markers of tissue hypoxia, such as central venous-to-arterial carbon dioxide
difference (PcvaCO2 gap) has been proposed. In the present study, we aimed to evaluate the ability of the PcvaCO2
gap and the PcvaCO2/arterial-venous oxygen content difference ratio (PcvaCO2/CavO2) to predict lactate evolution in
septic shock.
Methods: Observational study. Septic shock patients within the first 24 hours of ICU admission. After restoration of
mean arterial pressure, and central venous oxygen saturation, the PcvaCO2 gap and the PcvaCO2/CavO2 ratio were
calculated. Consecutive arterial and central venous blood samples were obtained for each patient within 24 hours.
Lactate improvement was defined as the decrease≥ 10% of the previous lactate value.
Results: Thirty-five septic shock patients were studied. At inclusion, the PcvaCO2 gap was 5.6 ± 2.1 mmHg, and the
PcvaCO2/CavO2 ratio was 1.6 ± 0.7 mmHg · dL/mL O2. Those patients whose lactate values did not decrease had
higher PcvaCO2/CavO2 ratio values at inclusion (1.8 ± 0.8vs. 1.4 ± 0.5, p 0.02). During the follow-up, 97 paired blood
samples were obtained. No-improvement in lactate values was associated to higher PcvaCO2/CavO2 ratio values in
the previous control. The ROC analysis showed an AUC 0.82 (p < 0.001), and a PcvaCO2/CavO2 ratio cut-off value of
1.4 mmHg · dL/mL O2 showed sensitivity 0.80 and specificity 0.75 for lactate improvement prediction. The odds ratio
of an adequate lactate clearance was 0.10 (p < 0.001) in those patients with an elevated PcvaCO2/CavO2 ratio (≥1.4).
Conclusion: In a population of septic shock patients with normalized MAP and ScvO2, the presence of elevated
PcvaCO2/CavO2 ratio significantly reduced the odds of adequate lactate clearance during the following hours.Introduction
Current guidelines for hemodynamic management of
severe sepsis and septic shock recommend the use of glo-
bal markers of tissue hypoxia as resuscitation endpoints
[1,2]. In the initial resuscitation period, targeting either
central venous oxygen saturation (ScvO2) normalization or* Correspondence: jmesquida@tauli.cat
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unless otherwise stated.lactate clearance, or the combination of both, is accepted
[1,3,4]. However, each one of these two variables has their
own limitations. Although the use of ScvO2 seems to pro-
vide more real-time information than lactate clearance,
the nature of septic conditions, characterized by microcir-
culatory heterogeneity that generates capillary shunting, is
frequently accompanied by elevated ScvO2 values. Indeed,
abnormally high ScvO2 values have been associated with
increased mortality in septic shock patients [5,6]. Achieve-
ment of the recommended normalized ScvO2 valuesral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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persistent tissue hypoxia, and some authors consider that
ScvO2 should be used in combination with other tissue
perfusion endpoints [7]. On the other hand, despite lactate
clearance being proven to be as beneficial as ScvO2 in
guiding resuscitation in sepsis, at the bedside the clinician
has to face the uncertainty of a high lactate value, without
knowing whether this lactate reflects persistence of hypo-
perfusion or whether its normalization is just a matter of
time [8]. On the whole, elevated lactate values could lead
to unnecessary interventions, with their potential deleteri-
ous effects, such as tissue edema and increased fluid bal-
ance, which have consistently been associated with worse
outcome [9].
Recently, some authors have advocated that the mixed
and/or central venous-to-arterial carbon dioxide differ-
ence (PcvaCO2 gap) might be complementary tools to
identify patients with persistent global hypoperfusion
[10]. Certainly, both partial pressure of carbon dioxide
gaps have demonstrated their prognostic value in different
conditions [11-14], and a cutoff value of 6 mmHg seems
to reflect whether global flow is adequate (gap >6 mmHg)
or insufficient (gap ≥6 mmHg). In addition, some authors
have suggested that correcting the PcvaCO2 gap by an ap-
proximation of the oxygen consumption, the PcvaCO2/ar-
terial-to-venous oxygen content difference (CavO2) ratio,
might be superior to the PcvaCO2 gap to detect anaerobic
metabolism [15], and therefore should be a more reliable
parameter to guide the resuscitation process.
In the present study, we addressed the question of
whether the PcvaCO2 gap and the PcvaCO2/CavO2 ratio
are useful in predicting the evolution of lactate, reflecting
the persistence of tissue hypoperfusion and/or anaerobic
metabolism. For that purpose, we studied a well-defined
population of patients with severe sepsis or septic shock,
once normalized ScvO2 values were achieved.
Preliminary data from this study were presented at




We conducted a retrospective observational study in a 30-
bed mixed ICU at a university hospital. Study approval
and waived consent were authorized by the local ethics
committee (Comitè Ètic d’Investigació Clínica, Fundació
Parc Taulí; Reference CEIC 2014637).
Patients and data collection
Septic shock patients within the first 24 hours of ICU
admission were studied. Severe sepsis and septic shock
were defined according to international sepsis definitions
[16]. All patients were resuscitated following the Surviving
Sepsis Campaign guidelines [1]. Exclusion criteria were:age under 18 years, and the presence of an uncontrolled
source of infection. Once normalized values of mean ar-
terial pressure (MAP ≥65 mmHg) and ScvO2 (≥70%) were
achieved, and the medical team in charge decided not to
perform further resuscitation interventions (such as vol-
ume expansion and/or changes in inotropic or vasopres-
sor drugs), simultaneous blood samples were obtained
from a central venous line and an arterial catheter. The
investigators confirmed the correct positioning of the ven-
ous catheter tip on chest X-ray examinations. Measured
variables included arterial oxygen tension (PaO2), arterial
carbon dioxide tension (PaCO2), central venous oxygen
tension (PcvO2), and central venous carbon dioxide ten-
sion (PcvCO2). Arterial oxygen saturation (SaO2) and
ScvO2 were calculated from the oxyhemoglobin disso-
ciation curve. Arterial and central venous lactate, and
hemoglobin concentration (Hb) were also measured. The
arterial oxygen content (CaO2), central venous oxygen
content (CvO2), CavO2, oxygen extraction ratio (O2ER),
PcvaCO2 gap, and PcvaCO2/CavO2 ratio were calculated ac-
cording to the following formulas:
CaO2 ¼ 1:34 SaO2 Hbð Þ þ 0:003 PaO2ð Þ
CcvO2 ¼ 1:34 ScvO2 Hbð Þ þ 0:003 PcvO2ð Þ
C a−vð ÞO2 ¼ CaO2−CcvO2
PcvaCO2gap ¼ PcvCO2−PaCO2
PcvaCO2=CavO2ratio ¼ PcvaCO2gap=C a−vð ÞO2
O2ER ¼ CavO2=CaO2
All consecutive paired blood samples (arterial and cen-
tral venous) obtained for each studied patient within the
following 24 hours, as indicated by the medical team,
were also collected.
Patient demographics, diagnosis at ICU admission,
sepsis origin, and Simplified Acute Physiology Score II
score were recorded at inclusion. Hemodynamic vari-
ables (heart rate and arterial pressure) were recorded by
routine bedside monitoring (Monitor Intellivue MP 70;
Phillips Medizinsystems, Boeblingen, Germany). Arterial
and central venous blood gas samples were analyzed
using point-of-care equipment (ABL 700 series; Radiom-
eter Medical, Copenhagen, Denmark).
Patients were followed during the whole ICU stay, and
the ICU length of stay and ICU mortality were computed.
Statistical analysis
Statistical analysis was performed by means of IBM SPSS
statistics 20.0 software (IBM Corporation, Armonk, New
York, USA). Normal distribution of the studied variables
was confirmed using the Kolmogorov–Smirnov test.
Accordingly, continuous variables were expressed as
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were expressed as the absolute number and proportions
(%). A descriptive analysis was performed. Correlations
between PcvaCO2 gap, PcvaCO2/CavO2 ratio, ScvO2, and
lactate were explored using the Pearson test. According
to previous published studies exploring the value of lac-
tate clearance, lactate improvement was defined as the
decrease of at least 10% of the previous lactate value
[3,17]. Comparisons between lactate improvers and non-
improvers were performed with the Mann–Whitney U
test (first set of measurements) and Student’s t test (for
the whole paired measurements) for continuous vari-
ables, and with the chi-square test or Fisher’s exact test
for categorical variables. The ability of the PcvaCO2/
CavO2 ratio for predicting a decrease in lactate ≥10%
was calculated using a receiver operator characteristic
(ROC) curve, and a clinically relevant cutoff value was
computed. Binary logistic regression was used to deter-
mine the odds ratio of an adequate lactate clearance for
the PcvaCO2 gap and the PcvaCO2/CavO2 ratio. Two-tailed
P <0.05 was taken to indicate statistical significance.Table 1 Patient demographic, hemodynamic, and metabolic c
All (n = 35) Lactate im
Age (years) 65 ± 13 63 ± 14
Male 22 (63) 10 (59)
Etiology
Respiratory 8 (23) 4 (24)
Abdominal 14 (40) 7 (41)
Urinary tract 4 (11) 3 (18)
Soft tissue 5 (14) 1 (6)
Other 4 (11) 2 (12)
SAPS II 49 ± 11 47 ± 9
SOFA score (day 1) 9 ± 3 9 ± 3
Mechanical ventilation 28 (80) 14 (82)
Heart rate (beats per minute) 103 ± 14 103 ± 17
MAP (mmHg) 78 ± 12 82 ± 11
Norepinephrine use (%) 100 100
Norepinephrine dose (μg/kg/minute) 0.86 ± 0.65 0.66 ± 0.5
Hemoglobin (g/dl) 11.2 ± 2.0 12.2 ± 1.7
ScvO2 (%) 71 ± 8 71 ± 8
Lactate (mg/dl) 38 ± 48 30 ± 15
PcvaCO2 gap (mmHg) 5.6 ± 2.1 5.1 ± 1.9
PcvaCO2/CavO2 ratio (mmHg · dl/ml O2) 1.6 ± 0.7 1.3 ± 0.4
O2ER 0.26 ± 0.09 0.25 ± 0.09
ICU length of stay (days) 15 ± 10 17 ± 14
Mortality 10 (29) 3 (18)
Data presented as mean ± standard deviation or number (%). MAP, mean arterial pr
carbon dioxide difference; PcvaCO2/CavO2 ratio, central venous-to-arterial carbon dio
Simplified Acute Physiological Score; ScvO2, central venous oxygen saturation; SOFAResults
Thirty-five septic shock patients were studied. Demo-
graphic, hemodynamic, and metabolic characteristics are
presented in Table 1. At inclusion, patients had values of
MAP 78 ± 12 mmHg, ScvO2 71 ± 8%, and venous lactate
39 ± 49 mg/dl. The calculated PcvaCO2 gap was 5.6 ± 2.1
mmHg, and the PcvaCO2/CavO2 ratio was 1.6 ± 0.7
mmHg · dl/ml O2. No correlation between simultaneous
ScvO2 and lactate was observed. The PcvaCO2 gap at inclu-
sion was inversely correlated to ScvO2 (r = –0.7, P <0.001),
whereas the PcvaCO2/CavO2 ratio directly correlated to
lactate values (r = 0.73, P <0.001). The first consecutive
paired blood samples were obtained after 3 ± 2 hours,
none of them following additional resuscitation interven-
tions. When compared with patients whose lactate values
decreased, those patients whose lactate values did not de-
crease showed similar baseline PcvaCO2 gap values at in-
clusion (6.1 ± 2.3 vs. 5.1 ± 1.9 mmHg, P = 0.09), whereas
significantly higher PcvaCO2/CavO2 ratio values at inclu-
sion were observed (1.8 ± 0.8 vs. 1.3 ± 0.4 mmHg · dl/ml
O2, P = 0.02). No differences in initial ScvO2 or lactateharacteristics at inclusion
provers (n = 17) Lactate nonimprovers (n = 18) P value







50 ± 12 0.5
9 ± 3 0.6
14 (78) 0.5
104 ± 13 0.8
71 ± 10 0.08
100 1
1.01 ± 0.75 0.05
9.9 ± 2.0 0.02
72 ± 8 0.7
46 ± 65 0.8
6.1 ± 2.3 0.09
1.8 ± 0.8 0.02
0.25 ± 0.08 0.9
13 ± 10 0.5
7 (39) 0.2
essure; O2ER, oxygen extraction ratio; PcvaCO2 gap, central venous-to-arterial
xide difference/arterial-to-central venous oxygen content difference ratio; SAPS,
, Sequential Organ Failure Assessment.
Mesquida et al. Critical Care  (2015) 19:126 Page 4 of 7were observed according to lactate clearance (Table 1).
The PcvaCO2/CavO2 ratio ROC analysis showed an area
under the curve of 0.75 (95% confidence interval = 0.6
to 0.92, P = 0.01) for adequate initial lactate clearance
prediction.
Twenty-four-hour follow-up
During the follow-up period, 97 paired blood samples
were obtained. The number of paired samples for each
studied patient is shown in Figure 1. The elapsed time
between consecutive measurements was 3 ± 2 hours.
No improvement in lactate values was associated with
higher PcvaCO2/CavO2 ratio values in the previous
measurement (1.9 ± 0.9 vs. 1.2 ± 0.4 mmHg · dl/ml O2,
P <0.001), while PcvaCO2 gap values did not statisti-
cally differ (6.0 ± 2.3 vs. 5.0 ± 2.1 mmHg, P = 0.08).
Higher ScvO2 values were also observed in those patients
whose lactate did not decrease within the following hours
(73 ± 8% vs. 68 ± 9%, P = 0.01). When exploring the
ability of these parameters in predicting adequate lac-
tate clearance, for the whole 97 paired samples the
PcvaCO2/CavO2 ratio ROC analysis showed an area
under the curve of 0.82 (95% confidence interval = 0.73
to 0.92, P <0.001), and a cutoff value of 1.4 had the best
relationship between sensitivity (0.8) and specificity
(0.75). The PcvaCO2 gap ROC analysis showed an area
under the curve of 0.62 (P = 0.07) for lactate improve-
ment prediction. The odds ratio of an adequate lactate
clearance was 0.10 (95% confidence interval = 0.03 to
0.3, P <0.001) in those patients with an elevated
PcvaCO2/CavO2ratio (≥1.4), whereas it did not reach
statistical significance (P = 0.1) for those patients with a
PcvaCO2 gap ≥6 mmHg.Figure 1 Number of paired samples for each studied patient under th
two consecutive (3 ± 2 hours) simultaneous arterial and central venous bloOutcome
The mortality in the studied population was 29% (10 pa-
tients). Patients who died had similar lactate, ScvO2, and
PcvaCO2 gap values at inclusion, but showed significantly
increased PcvaCO2/CavO2 ratio values (1.9 ± 0.9 in non-
survivors vs. 1.4 ± 0.45 in survivors, P = 0.03) (Table 2).
Discussion
The main result of our study is that, in a population of
septic shock patients, once MAP and ScvO2 values were
normalized, high PcvaCO2/CavO2 ratio values were asso-
ciated with the lack of lactate clearance within the fol-
lowing hours, and this condition was associated with
patient mortality. In our population, the ability of the
PcvaCO2/CavO2 ratio to predict lactate evolution was
stronger than that of the PcvaCO2 gap. To our know-
ledge this is the first study exploring this issue, and our
data validate that integration of the PcvaCO2/CavO2 ratio
within the resuscitation process of septic shock might
have relevant clinical utility.
The present study aimed to add some information for
a daily clinical question, such as whether to stop or
continue resuscitating those patients suffering from sep-
tic shock once MAP and ScvO2 endpoints have been
reached but lactate values are still elevated. According to
current international guidelines [1], normalization of
ScvO2 as a global marker for the adequacy of tissue
oxygenation would be sufficient. On the other hand, using
lactate clearance as guidance for the resuscitation process
has been demonstrated to be as effective as ScvO2 guid-
ance [3]. However, the real-time nature of ScvO2 monitor-
ing has been decisive for its widespread use above lactate
monitoring. In clinical practice, an adequate knowledge ofe 24-hour follow-up period. Each pair of measurements consists of
od samples, allowing for lactate clearance calculation.
Table 2 Patients’ main characteristics according to ICU survival
Survivors (n = 25) Nonsurvivors (n = 10) P value
Age (years) 65 ± 13 67 ± 13 0.6
SAPS II 47 ± 10 53 ± 12 0.5
SOFA (day 1) 9 ± 3 9 ± 3 0.7
Heart rate (beats per minute) 103 ± 15 103 ± 12 0.9
MAP (mmHg) 81 ± 11 69 ± 12 0.07
Norepinephrine dose (mcg/kg/min) 0.85 ± 0.65 0.93 ± 0.73 0.7
Hemoglobin (g/dl) 11.7 ± 1.8 9.6 ± 2.1 0.1
ScvO2 (%) 71 ± 9 71 ± 6 0.9
Lactate (mg/dl) 25 ± 10 69 ± 83 0.8
PcvaCO2 gap (mmHg) 5.4 ± 2.3 6.0 ± 1.5 0.3
PcvaCO2/CavO2 ratio (mmHg · dl/ml O2) 1.4 ± 0.5 1.9 ± 0.9 0.03
ΔSOFA (day 4) –3 ± 3 1 ± 4 0.02
Data presented as mean ± standard deviation or number (%). Main characteristics at inclusion are shown. During the follow-up period, the SOFA evolution within
4 days was also associated with higher mortality rates. MAP, mean arterial pressure; PcvaCO2 gap, central venous-to-arterial carbon dioxide difference; PcvaCO2/
CavO2 ratio, central venous-to-arterial carbon dioxide difference/arterial-to-central venous oxygen content difference ratio; SAPS, Simplified Acute Physiological
Score; ScvO2, central venous oxygen saturation; ΔSOFA, SOFA score at day 4 – SOFA score at day 1; SOFA, sequential Organ Failure Assessment.
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able in order to understand each scenario, and take deci-
sions accordingly. In recent years, some studies have
corroborated the prognostic value of the PcvaCO2 gap in
several clinical conditions [11-14], and this parameter has
been proposed as an additional marker of tissue perfusion
adequacy [10]. Importantly, its value seems to persist even
when ScvO2 has been normalized [11,13,14]. According to
these observations, it has been suggested that adding the
PcvaCO2 gap as a supplementary endpoint in the resuscita-
tion process of septic shock might prove beneficial [10],
but to date prospective interventional studies exploring
this issue are still lacking. Moreover, some authors have
suggested that correcting the PcvaCO2 gap by the CavO2
(PcvaCO2/CavO2 ratio) might enhance its value as a marker
of anaerobic metabolism [15,18]. The PcvaCO2/CavO2 ratio
has been proposed as an approximation of the respiratory
quotient, the relationship between global carbon dioxide
production and global oxygen consumption (VO2). Ac-
cording to Fick’s equation, VO2 is equal to the product of
cardiac output and the CavO2. Similarly, global carbon di-
oxide production is equal to the product of cardiac output
and the central venous-to-arterial carbon dioxide content
difference. The respiratory quotient is therefore equal to
the central venous-to-arterial carbon dioxide content dif-
ference/CavO2 ratio. Increased carbon dioxide production,
relative to oxygen consumption, occurs under conditions
of tissue hypoxia, and the presence of anaerobic metabol-
ism may be inferred when the respiratory quotient rises
above 1. Since over the physiological range of carbon di-
oxide contents the partial pressure of carbon dioxide is
linearly related to carbon dioxide content, using the
PcvaCO2 as a surrogate for the carbon dioxide content dif-
ference has been previously accepted [15,18]. In thepresent study, we aimed at exploring whether an increased
PcvaCO2 gap and its combination with the CavO2 at the
end of early goal-directed therapy would be predictive of
an inadequate lactate clearance, and thus a ready-to-use
tool for the decision-making process.
The PcvaCO2/CavO2 ratio as a marker of anaerobic
metabolism
Mekontso-Dessap and coworkers suggested that the
PcvaCO2/CavO2 ratio might be a reflection of anaerobic
metabolism, demonstrating a positive correlation be-
tween this parameter and lactate [15]. Indeed, in their
study the PcvaCO2/CavO2 ratio was superior to ScvO2
and the PcvaCO2 gap for predicting elevated lactate
values. Our study was designed to go one step further,
and we explored the ability of the PcvaCO2/CavO2 ratio
to predict the adequacy of lactate clearance. Again, our
results support the hypothesis that the PcvaCO2/CavO2
ratio is a better predictor of anaerobic metabolism than
the PcvaCO2 gap. Of note, lactate values at inclusion
were not associated with lactate evolution, strengthening
the concept that an elevated lactate value at a given time
point does not infer the presence of anaerobic metabol-
ism. In a recent study, Monnet and coworkers nicely
showed that, after performing a volume expansion,
among those patients who were considered to be re-
sponders (increase in cardiac output) only patients with
an elevated PcvaCO2/CavO2 ratio at baseline increased
their VO2 [18]. In other words, the ability to increase
the metabolic rate, after increasing oxygen availability,
was only observed in those patients with an altered
PcvaCO2/CavO2 ratio. According to their results, the au-
thors introduced the idea that VO2 might only increase
in response to an increase in global oxygen delivery
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as suggested by an elevated PcvaCO2/CavO2 ratio. Regret-
tably, we did not calculate VO2 or global oxygen delivery
in our patients. However, on the whole our data are in
accordance with these previous observations, and we
might hypothesize that those patients whose PcvaCO2/
CavO2 ratio was high might have a limited VO2, causing
anaerobic metabolism, and consequently were not able to
decrease their lactate values within the following hours.
Outcome
Although the present study was not powered to explore
the prognostic value of the PcvaCO2 gap and the PcvaCO2/
CavO2 ratio in terms of organ failure evolution or survival,
our data suggest a significant association between mortal-
ity and the presence of an elevated PcvaCO2/CavO2 ratio at
the end of early goal-directed therapy. The association
between the PcvaCO2 gap and outcome has been demon-
strated consistently in several scenarios, even in the pres-
ence of a normalized ScvO2 [11-14]. Although we were
not able to reproduce the prognostic value of the PcvaCO2
gap, our data suggest that the prognostic significance is
enhanced when correcting the PcvaCO2 gap for the oxygen
content difference. Independently of our results regarding
mortality, the demonstration that the PcvaCO2/CavO2 ratio
can predict the evolution of lactate strengthens its value,
and brings this parameter closer to clinical practice. Since
lactate clearance adequacy has already, and repeatedly,
been associated with outcome [4,17], the ability to predict
lactate evolution might prove useful in order to perform
further resuscitation maneuvers, or to avoid unnecessary
interventions and in doing so elude their potential dele-
terious effects.
Study limitations
Several limitations might be taken into account when
considering our results. Firstly, this is a single-center
study, so our results might have limitations when trying to
generalize for other ICUs or other settings. On the other
hand, the homogeneity of our resuscitation process would
strengthen the value of the observed results. Secondly, we
failed to demonstrate a relationship between the PcvaCO2
gap and lactate clearance, but the observed tendency to
higher PcvaCO2 gap values in those patients unable to de-
crease their lactate might suggest that the limited number
of patients studied would account for this lack of signifi-
cance. An additional limitation would derive from the lack
of standardization of the time points of lactate measure-
ment. Since this is an observational study, paired blood
gas analyses were performed according to the medical
team, without intervention from the researchers. Although
current practice in our ICU includes the verification
of a persistent normalized ScvO2 and confirming an ad-
equate lactate clearance, the timing of this verification isinconstant. Therefore, our second pair of measurements
was associated with time variability. Nevertheless, the
elapsed time between measurements was 3 ± 2 hours,
which is in accordance with previous clinical works pro-
spectively evaluating lactate clearance and outcome [3,4].
When exploring the prognostic value of the PcvaCO2/
CavO2 ratio, we might be cautious with the observed
results. As discussed above, the present study was not
designed for this purpose, and the reduced sample size
might limit the significance of the association with mortal-
ity, as suggested by the absence of prediction of mortality
by the Simplified Acute Physiology Score II. Although the
existing literature has proposed the PcvaCO2/CavO2 ratio
as a surrogate of the respiratory quotient, several situa-
tions might affect the relationship between carbon dioxide
content and partial pressure of carbon dioxide, such as the
Haldane effect [19]. Oxygen saturations were calculated
from partial pressure of oxygen values, not measured by
co-oximetry, with a potential source of error in the dis-
played ScvO2 values. Finally, we analyzed the value of the
PcvaCO2 gap and the PcvaCO2/CavO2 ratio once the rec-
ommended ScvO2 goal was reached. However, since the
ScvO2 value might be limited in septic conditions, when
oxygen extraction deficit occurs, whether the PcvaCO2 gap
and the PcvaCO2/CavO2 ratio might be useful independ-
ently of ScvO2 deserves further study. Regrettably, this issue
was not addressed in our study.
Conclusions
In a population of septic shock patients with normalized
MAP and ScvO2, the presence of elevated PcvaCO2/CavO2
ratio values significantly reduced the odds of adequate
lactate clearance during the following hours. Integrating
this parameter in future resuscitation algorithms might
prove useful in order to obtain real-time information on
the adequacy of tissue perfusion, helping in the decision-
making process, such as when to continue resuscitating
the tissue and/or when to stop interventions, despite
high lactate levels.
Key messages
 In the presence of an elevated PcvaCO2/CavO2 ratio,
the odds of adequate lactate clearance are significantly
reduced.
 The PcvaCO2/CavO2ratio might be a useful parameter
in the resuscitation process, complimentary to ScvO2
and lactate.
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